Enliven Therapeutics
ELVN
#5628
Rank
โ‚ฌ0.80 B
Marketcap
16,41ย โ‚ฌ
Share price
-1.37%
Change (1 day)
-1.18%
Change (1 year)

EPS for Enliven Therapeutics (ELVN)

EPS in 2023 (TTM): -1,45ย โ‚ฌ

According to Enliven Therapeutics's latest financial reports the company's current EPS (TTM) is -1,35ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -0,53ย โ‚ฌ a decrease over its 2020 EPS that were of -0,41ย โ‚ฌ.

EPS history for Enliven Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,45ย โ‚ฌ
2021-0,53ย โ‚ฌ30.44%
2020-0,41ย โ‚ฌ